Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.

Castellazzi M, Bellini T, Trentini A, Delbue S, Elia F, Gastaldi M, Franciotta D, Bergamaschi R, Manfrinato M C, Volta C A, et al.